On Monday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was 5.54% up from the session before settling in for the closing price of $9.74. A 52-week range
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) established initial surge of 8.29% at $9.4, as the Stock market unbolted on Thursday, before settling in for the price
A new trading day began on Monday, with Phathom Pharmaceuticals Inc (NASDAQ: PHAT) stock price up 3.47% from the previous day of trading, before settling
As on Wednesday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) got off with the flyer as it spiked 8.48% to $8.57, before settling in for the price
On Friday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -5.26% drop from the session before settling in for the closing price of $9.69. A 52-week range
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) kicked off on Tuesday, up 4.16% from the previous trading day, before settling in for the closing price of $8.66.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) kicked off on Thursday, up 0.11% from the previous trading day, before settling in for the closing price of $8.91.
On Tuesday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -7.72% drop from the session before settling in for the closing price of $9.59. A 52-week range
On Monday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -9.12%% drop from the session before settling in for the closing price of $10.42. A 52-week range
On Friday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was 6.08% up from the session before settling in for the closing price of $10.03. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.